UPUrjeet A. Patel

Urjeet A. Patel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Urjeet A. Patel has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Postoperative Opioid Receipt After Parotidectomy and Associations With Persistent Opioid Use Disorder

    by Asher C. Park, Milan P. Fehrenbach, Larry W. Wang, Oluwatobiloba Ayo‐Ajibola, Urjeet A. Patel, Sandeep Samant, Katelyn O. Stepan

    Objective: To investigate the association between postoperative opioid receipt and the development of persistent opioid use disorder following parotidectomy. Study Design: Propensity‐matched retrospective cohort study. Setting: United States. Methods: The TriNetX Research Network was queried for adult patients who underwent parotidectomy from 2010 to 2023. Patients with a history of opioid abuse/dependence or underwent surgery with anesthesia within 9 months postoperatively were excluded. The opioid cohort included patients that received hydrocodone, oxycodone, or codeine postoperatively, whereas the nonopioid cohort included patients that did not receive these opioids postoperatively. Cohorts were propensity score matched for patient demographics, psychiatric and preoperative pain diagnoses, as well as for possible procedures performed concurrently alongside parotidectomy. The primary outcome was risk of persistent opioid use, defined as new opioid use 3 to 9 months following surgery. Secondary outcomes included the number of emergency department and office/outpatient visits within 1 and 3 months postoperatively and the risk of opioid abuse/dependence. Results: After propensity matching, each cohort had 3858 patients. The opioid cohort had an increased risk of developing new persistent opioid use (RR = 1.321, P < .001) compared to the nonopioid cohort. Opioid receipt was also associated with increased office/outpatient visits within 1 ( P < .001) and 3 months ( P < .001). The number of emergency department visits and risk of opioid abuse/dependence were not significantly different between cohorts. Conclusion: Opioid prescription following parotidectomy was associated with an increased risk of persistent opioid use disorder and the number of postoperative office visits, emphasizing the need for further investigation of opioid‐sparing analgesia protocols following parotidectomy.


  • Open Access

    Association of Neighborhood‐Level Area Deprivation with Demographics and Outcomes in Oropharyngeal Squamous Cell Carcinoma

    by Shravan Asthana, Asher C. Park, Abhinav Talwar, Kirsten B. Burdett, Christopher Puchi, Ahmed Ibrahim, Olivia Dunne, Urjeet Patel, Sandeep Samant, Katelyn O. Stepan

    Objective: To characterize neighborhood‐level area deprivation's association with oropharyngeal carcinoma clinicodemographics, tumor staging, recurrence, and overall survival.Study Design: Retrospective study.Setting: Single institution academic medical center.Methods: Patients diagnosed with oropharyngeal squamous cell carcinoma (OPSCC) between 2007 and 2022 at our institution were included in this study. The Area Deprivation Index (ADI) was used to quantify neighborhood‐level disadvantage based on patients’ primary residence at the time of their diagnosis. Continuous variables were compared between groups using the Wilcoxon rank sum test. For categorical variables, proportions were compared using Fisher's exact test. Overall survival (OS) and recurrence‐free survival (RFS) distributions were estimated using the Kaplan‐Meier method and log‐rank test. OS and RFS were further assessed by univariable and multivariable analyses performed using the Cox proportional hazards model.Results: The higher ADI (more disadvantaged) group consisted of a significantly greater proportion of Black race (P < .001), 10+ pack‐year smoking history (P = .003), and Medicare patients (P = .018). On logistic regression analysis, neither ADI nor other social factors were significantly associated with increased likelihood of advanced clinical staging in the p16 positive OPSCC population. Furthermore, while ADI did not correspond with significant differences in survival, multivariate cox regression model demonstrated that “Other” insurance type (Medicaid and uninsured) (hazard ratio [HR] = 10.1, P = .008), age at diagnosis (1.10, P < .001), and advanced clinical staging (HR = 3.25, P = .004) were all significantly associated with increased HR of death.Conclusion: While ADI may not be significantly associated with outcomes in HPV‐related OPSCC patients, this study revealed significant sociodemographic and risk factor differences across ADIs, as well as individual factors influencing prognosis. These findings emphasize the need for a comprehensive approach to understanding factors influencing HPV‐related OPSCC incidence and prognosis.


  • Open Access

    Influence of Social Vulnerability in Treatment and Prognosis of Squamous Cell Carcinoma of the Tongue

    by David J. Fei‐Zhang, Asher C. Park, Daniel C. Chelius, Stephanie S. Smith, Sandeep Samant, Urjeet A. Patel, Anthony M. Sheyn, Jeffrey C. Rastatter

    Objective: To investigate the association of social determinants of health (SDoH) in squamous cell carcinoma of the tongue in the United States and to evaluate the real‐world contribution of specific disparities.Study Design: Retrospective cohort study.Setting: United States.Methods: The Centers for Disease Control and Prevention‐Social Vulnerability Index (SVI) and National Cancer Institute‐Surveillance, Epidemiology, and End Results Program database were used to study 62,103 adult tongue squamous cell carcinoma patients from 1975 to 2017. Regression analysis assessed trends in months of follow‐up and survival across social vulnerability and 4 subcategories of social vulnerability.Results: As overall SVI score increases (increased social vulnerability), there is a significant decrease in the average length of follow‐up (22.95% decrease from 63.99 to 49.31 months; P < .001) across patients from the lowest and highest social vulnerability groups. As overall SVI score increases, there is a significant decrease in the average months of survival (28.00% decrease from 49.20 to 35.43 months; P < .001). There is also a significantly greater odds ratio (OR = 1.05; P < .001) of advanced cancer staging upon presentation at higher SVI scores. Patients with higher SVI scores have a lower OR (0.93; P < .001) of receiving surgery as their primary treatment when compared to patients with lower SVI scores. Patients with higher SVI scores also have a significantly greater OR (OR = 1.05; P < .001) of receiving chemotherapy as their primary treatment when compared to patients with lower SVI scores.Conclusion: Increased social vulnerability is shown to have a detrimental impact on the treatment and prognosis of patients with squamous cell carcinoma of the tongue.


  • Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer

    by Mitesh P. Mehta, Rebecca Prince, Zeeshan Butt, Bryce E. Maxwell, Brittni N. Carnes, Urjeet A. Patel, Katelyn O. Stepan, Bharat B. Mittal, Sandeep Samant

    Background: We assessed long‐term patient‐reported dysphagia and xerostomia outcomes following definitive surgical management with transoral robotic surgery (TORS) in patients with oropharyngeal cancer (OPC) via a cross‐sectional survey study.Methods: Patients with OPC managed with primary oropharyngeal surgery as definitive treatment at least 1 year ago between 2015 and 2019 were identified. The M. D. Anderson Dysphagia Inventory (MDADI) and Xerostomia Inventory (XI) scores were compared across treatment types (i.e., no adjuvant therapy [TORS‐A] vs. adjuvant radiotherapy [TORS+RT] vs. adjuvant chemoradiotherapy [TORS+CT/RT]).Results: The sample had 62 patients (10 TORS‐A, 30 TORS+RT, 22 TORS+CT/RT). TORS‐A had clinically and statistically significantly better MDADI scores than TORS+RT (p = 0.03) and TORS+CT/RT (p = 0.02), but TORS+RT and TORS+CT/RT were not significantly different. TORS‐A had clinically and statistically significantly less XI than TORS+RT (p < 0.01) and TORS+CT/RT (p < 0.01).Conclusions: Patients with OPC who have undergone TORS+RT or TORS+CT/RT following surgery face clinically worse dysphagia and xerostomia outcomes relative to patients who undergo TORS‐A.


  • Survival of Patients With Non‐Rhabdomyosarcoma Soft Tissue Sarcomas of the Head and Neck

    by Jeffrey C. Rastatter, Rebecca N. Sinard, Amanda Dilger, Jennifer Reichek, David O. Walterhouse, Urjeet Patel

    Objective: To evaluate factors associated with overall survival (OS) of patients with non‐rhabdomyosarcoma soft tissue sarcomas of the head and neck.Study Design: Retrospective cohort study.Methods: The National Cancer Database was queried for cases of non‐rhabdomyosarcoma soft tissue sarcomas of the head and neck between 2004 and 2014. Cases were categorized according to the World Health Organization classification of soft tissue tumors. A multivariable Cox proportional hazards model was used to evaluate associations with OS.Results: A total of 4,555 patients (63.6% male, 36.4% female, mean age 59.6 years) met inclusion criteria. The majority of tumors were classified as miscellaneous (35.9%), followed by vascular (20.1%), smooth muscle (13.5%), fibroblastic/myofibroblastic (12.1%), peripheral nerve (8.5%), adipocytic (7.4%), and undifferentiated (2.5%) sarcomas. The mean follow‐up was 37.9 months, and overall mortality (MR) was 45.3%. The best prognosis was seen with fibroblastic/myofibroblastic sarcomas (MR = 20.6%, P < .001), whereas vascular sarcomas had the worst prognosis (MR = 67.6%, P < .001). Resection with clear margins had better OS than microscopically positive margins (hazard ratio [HR] = 1.43, P < .001) or grossly positive margins (HR = 2.97, P < .001). Radiation therapy was associated with better OS than no radiation (HR = 0.86, P = .001).Conclusion: Non‐rhabdomyosarcoma soft tissue sarcomas of the head and neck are associated with significant mortality. OS differs based on histologic subcategorization. Resection of the primary tumor with clear margins demonstrates improved OS for all histologies, suggesting this modality remains the preferred primary treatment when feasible.Level of Evidence: 3 Laryngoscope, 131:E500–E508, 2021


  • The submental flap for head and neck reconstruction: Comparison of outcomes to the radial forearm free flap

    by Urjeet A. Patel

    Objectives: To compare intraoperative, postoperative, functional, and oncologic outcomes of the submental island pedicled flap (SIPF) to the radial forearm free flap (RFFF).Study Design: Retrospective review; comparison with statistical analysis.Methods: A retrospective review was performed on patients at two tertiary care academic hospitals by a single surgeon. Consecutive patients who underwent cancer resection and reconstruction with SIPF or RFFF between 2004 and 2016 were included. Cancer staging, surgical procedure, hospital stay, complications, and functional and oncologic results were extracted.Results: The study included 146 patients (57 SIPF; 89 RFFF). The most prevalent primary site was oral cavity, with a minority in the oropharynx, paranasal sinuses, or external face. Mean area of the SIPF was smaller at 28 cm2 compared to 48 cm2 for the RFFF. Operative time for SIPF was shorter at 6.5 hours compared to 9 hours for RFFF. Hospital stay was 8.0 days for SIPF patients and 10.0 days for RFFF patients. Multivariate analysis confirmed these differences were significant. Functional outcomes of speech quality and gastrostomy feeding tube dependence were similar between the SIPF and RFFF groups. There was no difference in local recurrence rate for SIPF (16%) and RFFF (19%), and there was no difference in overall recurrence. Kaplan‐Meier curves showed no difference in recurrence between both groups, and multivariate logistic regression demonstrated no association between SIPF and local recurrence.Conclusion: Operative time and hospital stay are both significantly reduced with the SIPF. Functional and oncologic results are similar with no contraindication to the SIPF. The SIPF is a good first‐line choice for head and neck reconstruction.Level of Evidence: 3 Laryngoscope, 130:S1–S10, 2020


  • Open Access

    Multicenter Assessment of Antibiotic Prophylaxis Spectrum on Surgical Infections in Head and Neck Cancer Microvascular Reconstruction

    by Michael P. Veve, Joshua B. Greene, Amy M. Williams, Susan L. Davis, Nina Lu, Yelizaveta Shnayder, David X. Li, Salem I. Noureldine, Jeremy D. Richmon, Lawrence O. Lin, et al.

    Objective: To characterize and identify risk factors for 30‐day surgical site infections (SSIs) in patients with head and neck cancer who underwent microvascular reconstruction.Study Design: Cross‐sectional study with nested case‐control design.Setting: Nine American tertiary care centers.Subjects and Methods: Hospitalized patients were included if they underwent head and neck cancer microvascular reconstruction from January 2003 to March 2016. Cases were defined as patients who developed 30‐day SSI; controls were patients without SSI at 30 days. Postoperative antibiotic prophylaxis (POABP) regimens were categorized by Gram‐negative (GN) spectrum: no GN coverage, enteric GN coverage, and enteric with antipseudomonal GN coverage. All POABP regimens retained activity against anaerobes and Gram‐positive bacteria. Thirty‐day prevalence of and risk factors for SSI were evaluated.Results: A total of 1307 patients were included. Thirty‐day SSI occurred in 189 (15%) patients; median time to SSI was 11.5 days (interquartile range, 7‐17). Organisms were isolated in 59% of SSI; methicillin‐resistant Staphylococcus aureus (6%) and Pseudomonas aeruginosa (9%) were uncommon. A total of 1003 (77%) patients had POABP data: no GN (17%), enteric GN (52%), and antipseudomonal GN (31%). Variables independently associated with 30‐day SSI were as follows: female sex (adjusted odds ratio [aOR], 1.6; 95% CI, 1.1‐2.2), no GN POABP (aOR, 2.2; 95% CI, 1.5‐3.3), and surgical duration ≥11.8 hours (aOR, 1.9; 95% CI, 1.3‐2.7). Longer POABP durations (≥6 days) or antipseudomonal POABP had no association with SSI.Conclusions: POABP without GN coverage was significantly associated with SSI and should be avoided. Antipseudomonal POABP or longer prophylaxis durations (≥6 days) were not protective against SSI. Antimicrobial stewardship interventions should be made to limit unnecessary antibiotic exposures, prevent the emergence of resistant organisms, and improve patient outcomes.


  • Submental Island Pedicled Flap vs Radial Forearm Free Flap for Oral Reconstruction

    by Joseph A. Paydarfar, Urjeet A. Patel

    Research from JAMA Otolaryngology–Head & Neck Surgery — Submental Island Pedicled Flap vs Radial Forearm Free Flap for Oral Reconstruction — Comparison of Outcomes


  • Local response to chemoradiation in T4 larynx cancer with cartilage invasion

    by Urjeet A. Patel, Lori K. Howell

    Background: Patients with cartilage invasion were excluded from organ preservation protocols treating laryngeal and hypopharyngeal cancer. Treatment choice between chemoradiotherapy (CRT) and total laryngectomy (TL) remains controversial for these patients.Objective: To assess local response and local recurrence after CRT for patients having T4 larynx or hypopharynx cancer with cartilage invasion.Design: Retrospective intervention study.Setting: Tertiary‐care, urban public hospital.Patients: Patients with T4 squamous cell carcinoma of the larynx/hypopharynx with cartilage invasion treated from 2003 to 2009.Intervention: Curative‐intent CRT, compared to TL.Outcome Measures: Local response and local recurrence.Results: Of 34 patients included in this study, 21 completed CRT and 13 underwent TL with postoperative RT or CRT. With CRT, 19 patients were noted to have a complete response at the primary site while two patients had persistent local disease. Of 19 patients with complete response, 4 developed local recurrence over a time period 76–226 days (mean: 177 days). This resulted in a 29% incidence of persistent/recurrent disease at the primary site. The remaining 15 patients (71%) remained free of local disease (mean follow‐up: 369 days). For 13 patients undergoing TL with adjuvant therapy, there were no cases of local recurrence (mean follow‐up: 389 days).Conclusions: Although there was a high initial complete response rate after CRT, this response was not durable with a high local recurrence rate within 1 year. In comparison, patients undergoing TL demonstrated markedly better local control. For patients with cartilage invasion, a prospective trial comparing medical versus surgical therapy is needed. Laryngoscope, 2011